Literature DB >> 8558668

Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.

S J Jacobsen1, C J Girman, H A Guess, T Rhodes, J E Oesterling, M M Lieber.   

Abstract

PURPOSE: We report the results of 3 contacts during 42 months of The Olmsted County Study of Urinary Symptoms and Health Status Among Men, a longitudinal cohort study of men 40 to 79 years old that was initiated in 1990 to describe changes in lower urinary tract symptom severity.
MATERIALS AND METHODS: At baseline and followup, men completed questionnaires that elicited urinary symptom severity with questions nearly identical to those of the American Urological Association symptom index:
RESULTS: Overall, there was an average increase in American Urological Association symptom index of approximately 0.18 (95% confidence interval 0.13 to 0.24) points per year of followup. The average annual symptom score slope and variability in slope increased with patient age at baseline from a mean of 0.05 +/- 1.06 (standard deviation) per year among men in the forties to 0.44 +/- 1.35 per year for men in the sixties, and decreased to 0.14 +/- 1.42 per year for men in the seventies. The age-related changes in symptom severity mirror previous estimates of prostatic growth from autopsy prevalence studies.
CONCLUSIONS: These results demonstrate a slow but measurable progression in urinary symptom severity among community dwelling men for 42 months of followup.

Entities:  

Mesh:

Year:  1996        PMID: 8558668     DOI: 10.1016/s0022-5347(01)66461-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  52 in total

Review 1.  Benign prostatic hyperplasia.

Authors:  M J Barry; C G Roehrborn
Journal:  BMJ       Date:  2001-11-03

Review 2.  Drug treatments for lower urinary tract symptoms secondary to bladder outflow obstruction: focus on quality of life.

Authors:  Donald MacDonald; Thomas A McNicholas
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy.

Authors:  Kevin M Slawin; Michael W Kattan
Journal:  Rev Urol       Date:  2004

4.  The effects of type 2 diabetes and hypertension on changes in serum prostate specific antigen levels: results from the Olmsted County study.

Authors:  Lauren P Wallner; Hal Morgenstern; Michaela E McGree; Debra J Jacobson; Jennifer L St Sauver; Steven J Jacobsen; Aruna V Sarma
Journal:  Urology       Date:  2010-11-20       Impact factor: 2.649

5.  Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting.

Authors:  Amy E Krambeck; Debra J Jacobson; Michaela E McGree; Deborah J Lightner; Michael M Lieber; Steven J Jacobsen; Jennifer L St Sauver
Journal:  BJU Int       Date:  2012-04-03       Impact factor: 5.588

6.  Effect of Longbishu capsule () plus doxazosin on benign prostatic hyperplasia: a randomized controlled trial.

Authors:  Chun-Sheng Song; Jun Guo; De-Gui Chang; Lei Chen; Rui Zhang; Jia-You Zhao; Fu Wang; Qiang Zhang
Journal:  Chin J Integr Med       Date:  2014-06-18       Impact factor: 1.978

7.  BPH nomogram using IPSS, prostate volume, peak flow rate, PSA and median lobe protrusion for predicting the need for intervention: development and internal validation.

Authors:  Arvind P Ganpule; Rohan S Batra; Nitiraj B Shete; Abhishek G Singh; Ravindra B Sabnis; Mahesh R Desai
Journal:  Am J Clin Exp Urol       Date:  2021-06-15

Review 8.  Benign prostatic hyperplasia. Practical treatment guidelines.

Authors:  T Tammela
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

Review 9.  Lower urinary tract symptoms, benign prostatic hyperplasia, and obesity.

Authors:  Anne K Mongiu; Kevin T McVary
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

10.  Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

Authors:  Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.